N/A
Completed N=80
Promoting Cancer Symptom Management in Older Adults
Neoplasms · Chemotherapy-Induced Nausea and Vomiting
Source: ClinicalTrials.gov NCT03143829 ↗
Enrolled (actual)
80
Serious AEs
0.0%
Results posted
Dec 2021
Primary outcomePrimary: Symptom Severity Change Over Time — 4.13; 3.81 score on a scale — p=0.083
Summary
The purpose of the project is to estimate the effect size of a technology based intervention for older adults with cancer for nausea and vomiting. Participants will be randomized to either an intervention or a wait control group. Outcomes such as symptom severity, quality of life and resource use will be examined.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Symptom Severity Change Over Time |
4.13; 3.81 | 0.083 |
| PRIMARY Self-management Behaviors Over Time |
3.68; 1.38 | .099 |
| PRIMARY Health-related Quality of Life Change Over Time |
5.76; 5.91 | .558 |
| PRIMARY Resource Use Over Time |
19; 11 | .153 |
Eligibility Criteria
Inclusion Criteria
- Men and women age 65 and older
- newly diagnosed with any cancer
- treatment with any chemotherapeutic agent with a moderate to severe emetic potential (on a 3- or 4- week cycle)
- proficient in English
- have a telephone.
Exclusion Criteria
- Patients with previous diagnosis and treatment for cancer
- advanced or end stage disease with a palliative intent
- visually or hearing impaired.
Data sourced from ClinicalTrials.gov (NCT03143829). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.